IFF is watching the acquisition again while selling a pharmaceutical unit – but no more ‘frutaroma’

At the invitation with the Analysts at Wall Street after the Fortune 500 company reported on the results of 2024, the Erik Fyrwald CEO made it clear that the acquisitions were on the table again – but with a more disciplined approach. Read more



Source link